Skip to main content

Advertisement

Log in

Choroidal thickness profile and clinical outcomes in eyes with polypoidal choroidal vasculopathy

  • Retinal Disorders
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

To investigate the relationship between choroidal thickness (CT) profile and clinical outcomes after anti-vascular endothelial growth factor (VEGF) treatment in polypoidal choroidal vasculopathy (PCV).

Methods

Medical records of patients diagnosed with PCV who received anti-VEGF treatment over 12 months were reviewed. Subfoveal CT (SFCT) and peripapillary CT (PCT) were measured on swept-source optical coherence tomography images. Patients were divided into various groups based on choroidal profiles including SFCT, nasal PCT (nPCT) and ratio of SFCT to nPCT (SFCT/nPCT). Clinical outcomes were compared between the thin and thick CT groups.

Results

A total of 65 patients with PCV patients were included. After ant-VEGF treatment, SFCT was significantly decreased after anti-VEGF treatment (P = 0.001), but nasal PCT (nPCT) was not. Clinical outcomes were not different between the thin and thick SFCT groups. Total number of injections during the 12 months was significantly fewer in the thin nPCT group (3.4 ± 1.3) than in the thick nPCT group (4.5 ± 1.8) (P = 0.020). Complete resolution after loading injections was more frequently observed in the high SFCT/nPCT ratio (> 1.9) group (87.9%) than in the low SFCT/nPCT ratio (≤ 1.90) group (59.4%) (P = 0.009). The ratio of SFCT/nPCT showed the best predictive ability for poor responders (area under curve = 0.771).

Conclusion

These results suggest that baseline nPCT and SFCT/nPCT ratio could be a good biomarker that reflects clinical outcomes after anti-VEGF treatment in PCV.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

Data availability

We had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis as well as the decision to submit for publication.

References

  1. Spaide RF, Yannuzzi LA, Slakter JS, Sorenson J, Orlach DA (1995) Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy. Retina 15:100–110. https://doi.org/10.1097/00006982-199515020-00003

    Article  CAS  PubMed  Google Scholar 

  2. Yannuzzi LA, Sorenson J, Spaide RF, Lipson B (1990) Idiopathic polypoidal choroidal vasculopathy (IPCV). Retina 10:1–8

    Article  CAS  Google Scholar 

  3. Wong CW, Yanagi Y, Lee WK, Ogura Y, Yeo I, Wong TY, Cheung CMG (2016) Age-related macular degeneration and polypoidal choroidal vasculopathy in Asians. Prog Retin Eye Res 53:107–139. https://doi.org/10.1016/j.preteyeres.2016.04.002

    Article  PubMed  Google Scholar 

  4. Lee J, Byeon SH (2019) Prevalence and clinical characteristics of pachydrusen in polypoidal choroidal vasculopathy: multimodal image study. Retina 39:670–678. https://doi.org/10.1097/iae.0000000000002019

    Article  PubMed  Google Scholar 

  5. Ting DS, Ng WY, Ng SR, Tan SP, Yeo IY, Mathur R, Chan CM, Tan AC, Tan GS, Wong TY, Cheung CM (2016) Choroidal thickness changes in age-related macular degeneration and polypoidal choroidal vasculopathy: a 12-month prospective study. Am J Ophthalmol 164:128–136.e121. https://doi.org/10.1016/j.ajo.2015.12.024

    Article  PubMed  Google Scholar 

  6. Chung SE, Kang SW, Lee JH, Kim YT (2011) Choroidal thickness in polypoidal choroidal vasculopathy and exudative age-related macular degeneration. Ophthalmology 118:840–845. https://doi.org/10.1016/j.ophtha.2010.09.012

    Article  PubMed  Google Scholar 

  7. Gupta P, Ting DSW, Thakku SG, Wong TY, Cheng CY, Wong E, Mathur R, Wong D, Yeo I, Gemmy Cheung CM (2017) Detailed characterization of choroidal morphologic and vascular features in age-related macular degeneration and polypoidal choroidal vasculopathy. Retina 37:2269–2280. https://doi.org/10.1097/iae.0000000000001481

    Article  CAS  PubMed  Google Scholar 

  8. Chang YC, Cheng CK (2020) Difference between pachychoroid and nonpachychoroid polypoidal choroidal vasculopathy and their response to anti-vascular endothelial growth factor therapy. Retina. 40:1403–1411. https://doi.org/10.1097/iae.0000000000002583

    Article  CAS  PubMed  Google Scholar 

  9. Hayreh SS (2004) Posterior ciliary artery circulation in health and disease: the Weisenfeld lecture. Invest Ophthalmol Vis Sci 45:749–757; 748. https://doi.org/10.1167/iovs.03-0469

    Article  PubMed  Google Scholar 

  10. Yun C, Oh J, Ahn SE, Hwang SY, Kim SW, Huh K (2016) Peripapillary choroidal thickness in patients with early age-related macular degeneration and reticular pseudodrusen. Graefes Arch Clin Exp Ophthalmol 254:427–435. https://doi.org/10.1007/s00417-015-3054-7

    Article  PubMed  Google Scholar 

  11. Kang HM, Kim EW, Choi JH, Koh HJ, Lee SC (2020) Focal lamina cribrosa defects and significant peripapillary choroidal thinning in patients with unilateral branch retinal vein occlusion. PLoS One 15:e0230293. https://doi.org/10.1371/journal.pone.0230293

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Yun C, Oh J, Han JY, Hwang SY, Moon SW, Huh K (2015) Peripapillary choroidal thickness in central serous chorioretinopathy: is choroid outside the macula also thick? Retina 35:1860–1866. https://doi.org/10.1097/iae.0000000000000539

    Article  PubMed  Google Scholar 

  13. Nam KT, Chung HW, Jang S, Kim SW, Oh J, Yun C (2020) Features of the macular and peripapillary choroid and choriocapillaris in eyes with nonexudative age-related macular degeneration. Retina 40:2270–2276. https://doi.org/10.1097/iae.0000000000002758

    Article  CAS  PubMed  Google Scholar 

  14. Lee KH, Kim SH, Lee JM, Kang EC, Koh HJ (2017) Peripapillary choroidal thickness change of polypoidal choroidal vasculopathy after anti-vascular endothelial growth factor. Korean J Ophthalmol 31:431–438. https://doi.org/10.3341/kjo.2016.0101

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Lee B, Yoo G, Yun C, Oh J (2019) Short-term effects of anti-vascular endothelial growth factor on peripapillary choroid and choriocapillaris in eyes with neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 257:2163–2172. https://doi.org/10.1007/s00417-019-04432-w

    Article  CAS  PubMed  Google Scholar 

  16. Miyake M, Ooto S, Yamashiro K, Takahashi A, Yoshikawa M, Akagi-Kurashige Y, Ueda-Arakawa N, Oishi A, Nakanishi H, Tamura H, Tsujikawa A, Yoshimura N (2015) Pachychoroid neovasculopathy and age-related macular degeneration. Sci Rep 5:16204. https://doi.org/10.1038/srep16204

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Kim H, Lee SC, Kwon KY, Lee JH, Koh HJ, Byeon SH, Kim SS, Kim M, Lee CS (2016) Subfoveal choroidal thickness as a predictor of treatment response to anti-vascular endothelial growth factor therapy for polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol 254:1497–1503. https://doi.org/10.1007/s00417-015-3221-x

    Article  CAS  PubMed  Google Scholar 

  18. Kim JH, Lee TG, Chang YS, Kim CG, Cho SW (2016) Short-term choroidal thickness changes in patients treated with either ranibizumab or aflibercept: a comparative study. Br J Ophthalmol 100:1634–1639. https://doi.org/10.1136/bjophthalmol-2015-308074

    Article  PubMed  Google Scholar 

  19. Koizumi H, Kano M, Yamamoto A, Saito M, Maruko I, Sekiryu T, Okada AA, Iida T (2015) Aflibercept therapy for polypoidal choroidal vasculopathy: short-term results of a multicentre study. Br J Ophthalmol 99:1284–1288. https://doi.org/10.1136/bjophthalmol-2014-306432

    Article  PubMed  Google Scholar 

  20. Koizumi H, Kano M, Yamamoto A, Saito M, Maruko I, Kawasaki R, Sekiryu T, Okada AA, Iida T (2015) Short-term changes in choroidal thickness after aflibercept therapy for neovascular age-related macular degeneration. Am J Ophthalmol 159:627–633. https://doi.org/10.1016/j.ajo.2014.12.025

    Article  CAS  PubMed  Google Scholar 

  21. Koizumi H, Kano M, Yamamoto A, Saito M, Maruko I, Sekiryu T, Okada AA, Iida T (2016) Subfoveal choroidal thickness during aflibercept therapy for neovascular age-related macular degeneration: twelve-month results. Ophthalmology 123:617–624. https://doi.org/10.1016/j.ophtha.2015.10.039

    Article  PubMed  Google Scholar 

  22. Nagai N, Suzuki M, Minami S, Kurihara T, Kamoshita M, Sonobe H, Watanabe K, Uchida A, Shinoda H, Tsubota K, Ozawa Y (2019) Dynamic changes in choroidal conditions during anti-vascular endothelial growth factor therapy in polypoidal choroidal vasculopathy. Sci Rep 9:11389. https://doi.org/10.1038/s41598-019-47738-9

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Padron-Perez N, Arias L, Rubio M, Lorenzo D, Garcia-Bru P, Catala-Mora J, Caminal JM (2018) Changes in choroidal thickness after intravitreal injection of anti-vascular endothelial growth factor in pachychoroid neovasculopathy. Invest Ophthalmol Vis Sci 59:1119–1124. https://doi.org/10.1167/iovs.17-22144

    Article  CAS  PubMed  Google Scholar 

  24. Jang JW, Kim JM, Kang SW, Kim SJ, Bae K, Kim KT (2019) Typical polypoidal choroidal vasculopathy and polypoidal choroidal neovascularization. Retina 39:1995–2003. https://doi.org/10.1097/iae.0000000000002259

    Article  CAS  PubMed  Google Scholar 

  25. Shin JY, Kwon KY, Byeon SH (2015) Association between choroidal thickness and the response to intravitreal ranibizumab injection in age-related macular degeneration. Acta Ophthalmol 93:524–532. https://doi.org/10.1111/aos.12653

    Article  CAS  PubMed  Google Scholar 

  26. Tan CS, Ouyang Y, Ruiz H, Sadda SR (2012) Diurnal variation of choroidal thickness in normal, healthy subjects measured by spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci 53:261–266. https://doi.org/10.1167/iovs.11-8782

    Article  PubMed  Google Scholar 

  27. Sizmaz S, Kucukerdonmez C, Pinarci EY, Karalezli A, Canan H, Yilmaz G (2013) The effect of smoking on choroidal thickness measured by optical coherence tomography. Br J Ophthalmol 97:601–604. https://doi.org/10.1136/bjophthalmol-2012-302393

    Article  PubMed  Google Scholar 

  28. Lee M, Lee H, Kim HC, Chung H (2018) Changes in stromal and luminal areas of the choroid in pachychoroid diseases: insights into the pathophysiology of pachychoroid diseases. Invest Ophthalmol Vis Sci 59:4896–4908. https://doi.org/10.1167/iovs.18-25018

    Article  CAS  PubMed  Google Scholar 

  29. Maruko I, Iida T, Sugano Y, Saito M, Sekiryu T (2011) Subfoveal retinal and choroidal thickness after verteporfin photodynamic therapy for polypoidal choroidal vasculopathy. Am J Ophthalmol 151:594–603.e591. https://doi.org/10.1016/j.ajo.2010.10.030

    Article  CAS  PubMed  Google Scholar 

  30. Cho HJ, Kim HS, Jang YS, Han JI, Lew YJ, Lee TG, Kim CG, Kim JW (2013) Effects of choroidal vascular hyperpermeability on anti-vascular endothelial growth factor treatment for polypoidal choroidal vasculopathy. Am J Ophthalmol 156:1192–1200.e1191. https://doi.org/10.1016/j.ajo.2013.07.001

    Article  CAS  PubMed  Google Scholar 

  31. Jirarattanasopa P, Ooto S, Nakata I, Tsujikawa A, Yamashiro K, Oishi A, Yoshimura N (2012) Choroidal thickness, vascular hyperpermeability, and complement factor H in age-related macular degeneration and polypoidal choroidal vasculopathy. Invest Ophthalmol Vis Sci 53:3663–3672. https://doi.org/10.1167/iovs.12-9619

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

This study was supported by the Korea University grant (K2011221).

Author information

Authors and Affiliations

Authors

Contributions

Y.H.K: conception of the study, data collection, imaging analysis, drafting of the work, manuscript review and final approval. B.L and E.K: data collection, imaging analysis and manuscript review. J.O: data collection, interpretation of data, drafting of the manuscript, manuscript review and final approval.

Corresponding author

Correspondence to Jaeryung Oh.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethics approval

This study was performed in line with the principles of the Declaration of Helsinki and approved by the Institutional Review Board of the Korea University Hospital, Seoul, Korea (IRB number: 2020AN0159), and adhered to the tenets of the Declaration of Helsinki.

Consent to participate

This retrospective study involves no more than minimal risk to subjects, and the IRB of the Korea University Hospital approved our request to waive the informed consent.

Consent for publication

Not applicable.

Code availability

Not applicable.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

ESM 1

(DOCX 2065 kb)

ESM 2

(PDF 146 kb)

ESM 3

(PDF 216 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kim, Y.H., Lee, B., Kang, E. et al. Choroidal thickness profile and clinical outcomes in eyes with polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol 259, 1711–1721 (2021). https://doi.org/10.1007/s00417-020-05051-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-020-05051-6

Keywords

Navigation